Skip to the page

Data / Form D filings / Protea Biosciences Group, Inc.

Protea Biosciences Group, Inc.: Form D filings

Protea Biosciences Group, Inc., a biotechnology company in Morgantown, WV, filed 19 Form D notices with the SEC between 2011 and 2016. The latest, on November 17, 2016, reports $631,680 sold of a $5 million offering to 25 investors.

Find out what Protea Biosciences Group, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1311 PINEVIEW DRIVE, SUITE 501, Morgantown, WV, 26505
Phone
(304) 292-2226
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
$1,000,001 - $5,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1335103

The full lists. Form D filings in West Virginia: 24 rows, $5, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get this list free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 17, 2016New notice$5,000,000$631,680$4,368,32025Nov 3, 2016sec.gov
Jun 6, 2016New notice$2,500,000$691,000$1,809,00014May 20, 2016sec.gov
Sep 11, 2015New notice$4,000,000$452,500$3,547,5008Aug 27, 2015sec.gov
Jun 5, 2015New notice$2,000,000$2,000,000$01May 22, 2015sec.gov
Nov 14, 2014New notice$12,000,000$4,426,528$7,573,47257Oct 31, 2014sec.gov
Apr 17, 2014New notice$900,000$600,000$300,0001Apr 2, 2014sec.gov
Apr 17, 2014New notice$1,100,000$175,000$925,0001Apr 2, 2014sec.gov
Oct 30, 2013New notice$750,000$275,000$475,0002Oct 25, 2013sec.gov
Oct 23, 2013New notice$8,000,000$700,000$7,300,0006Sep 25, 2013sec.gov
Sep 5, 2013New notice$1,000,000$345,000$655,0003Aug 27, 2013sec.gov
Jul 29, 2013New notice$1,000,000$439,500$560,5008Jul 15, 2013sec.gov
Apr 25, 2013New notice$1,500,000$680,000$820,0005Apr 23, 2013sec.gov
Dec 27, 2012New notice$3,000,000$0$3,000,0000Dec 16, 2012sec.gov
Dec 14, 2012New notice$915,000$915,000$06Nov 30, 2012sec.gov
Sep 6, 2012New notice$6,000,000$450,000$5,550,0005Aug 22, 2012sec.gov
May 9, 2012New notice$6,000,000$305,000$5,695,0000May 4, 2012sec.gov
Jan 10, 2012New notice$10,000,000$280,000$9,720,00010Dec 27, 2011sec.gov
Nov 23, 2011New notice$10,000,000$200,000$9,800,0002Nov 10, 2010sec.gov
Sep 16, 2011New noticeIndefinite$0Indefinite206Sep 2, 2011sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Patrick T. GallagherDirector
Josiah T. AustinDirector
Ed A. RobersonDirector
Stephen A. TurnerExecutive Officer, Director
Steve T. HarrisDirector
David A. HalversonExecutive Officer
Steve T. AntolineDirector
Matthew T. PowellExecutive Officer
Scott A. SegalDirector
Maged T. ShenoudaDirector
Stanley A. HostlerExecutive Officer, Director

Every Form D from the week of Nov 14, 2016 · All recent filings in West Virginia · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Protea Biosciences Group, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.